REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Healthcare and pharma

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

1 2 3 4 5 11
Indonesia Pharma and Healthcare Sector Report 2026-2027 - Page 1
Indonesia Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

Indonesia has one of the fastest-growing pharmaceutical and healthcare sectors in ASEAN. The Indonesian government launched a comprehensive national health insurance scheme in 2014 to ensure that all Indonesians have access to healthcare. Almost all ...

View more details
USD 995 Date: April 2026 Language: English
Format: PDF
Add to basket
India Pharma and Healthcare Sector Report 2026-2027 - Page 1
India Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

India's pharmaceutical and healthcare sector is globally recognised. India's reputation as the "pharmacy of the world" was established through its extensive production of generic medications and vaccines. For example, the Serum Institute of India, a ...

View more details
USD 995 Date: February 2026 Language: English
Format: PDF
Add to basket
Malaysia Pharma and Healthcare Sector Report 2026-2027 - Page 1
Malaysia Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

Malaysia's pharmaceutical and healthcare sector ranks among the most sophisticated in Southeast Asia. Malaysia's healthcare system is segmented into a publicly funded, government-operated sector and a fee-paying private sector. The public healthcare ...

View more details
USD 995 Date: February 2026 Language: English
Format: PDF
Add to basket
China Pharmaceutical Sector Report 2025 Q4 - Page 1
China Pharmaceutical Sector Report 2025 Q4 EMIS Insights Industry Reports

Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...

View more details
USD 995 Date: January 2026 Language: English
Format: PDF
Add to basket
Thailand Pharma and Healthcare Sector Report 2026-2027 - Page 1
Thailand Pharma and Healthcare Sector Report 2026-2027 EMIS Insights Industry Reports

Thailand's pharmaceutical and healthcare industry has experienced substantial growth over the past few decades. In 2002, the Thai government launched a successful initiative to establish universal healthcare for all Thai citizens, guaranteeing ...

View more details
USD 995 Date: January 2026 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2025 Q4 - Page 1
China Healthcare Sector Report 2025 Q4 EMIS Insights Industry Reports

China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...

View more details
USD 995 Date: December 2025 Language: English
Format: PDF
Add to basket
China Pharmaceutical Sector Report 2025 Q3 - Page 1
China Pharmaceutical Sector Report 2025 Q3 EMIS Insights Industry Reports

Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...

View more details
USD 995 Date: November 2025 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2025 Q3 - Page 1
China Healthcare Sector Report 2025 Q3 EMIS Insights Industry Reports

China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...

View more details
USD 995 Date: September 2025 Language: English
Format: PDF
Add to basket
India Pharma and Healthcare Sector H1 FY2026 Half-Annual Review - Page 1
India Pharma and Healthcare Sector H1 FY2026 Half-Annual Review EMIS Insights Industry Reports

Regulatory changes significantly impacted the pharmaceuticals and healthcare sector during the half-year from March to September 2025. The government's decision to reform the Goods and Services Tax (GST) regime for the first time since its ...

View more details
USD 995 Date: September 2025 Language: English
Format: PDF
Add to basket
China Pharmaceutical Sector Report 2025 Q2 - Page 1
China Pharmaceutical Sector Report 2025 Q2 EMIS Insights Industry Reports

Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...

View more details
USD 995 Date: August 2025 Language: English
Format: PDF
Add to basket
1 2 3 4 5 11